TSMHT
EBS icon

Thurston Springer Miller Herd & Titak’s Emergent Biosolutions EBS Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22
Closed -$140 – 764
2025
Q2 		$140 Hold
22
– – ﹤0.01% 1613
2025
Q1 		$106 Buy
22
+3
+16% +$25 ﹤0.01% 1655
2024
Q4 		$181 Hold
19
– – ﹤0.01% 1306
2024
Q3 		$158 Hold
19
– – ﹤0.01% 1511
2024
Q2 		$129 Buy
+19
New +$82 ﹤0.01% 1499

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's EBS Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 22 shares — an estimated $140 sold.

Thurston Springer Miller Herd & Titak first reported a position in EBS in Q2 2024 and held it in 5 quarters. The position peaked at $181 in Q4 2024. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 22 Emergent Biosolutions shares in Q3 2025, an estimated $140.
  • Thurston Springer Miller Herd & Titak first reported a position in Emergent Biosolutions in Q2 2024 and held it in 5 quarters.
  • Thurston Springer Miller Herd & Titak's Emergent Biosolutions position peaked at $181 in Q4 2024.
  • 169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.